Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
中文摘要

《亚洲男性学杂志》 2012; 14 (3): 405-408

《亚洲男性学杂志》 2012; 14 (3): 405–408

Cyr61,一个潜在的前列腺癌预后生物标记物

Naoki Terada, Prakash Kulkarni and Robert H Getzenberg (美国)

富半胱氨酸血管生成诱导因子61(Cyr61)是一种细胞外基质蛋白,与生长因子和激素的信号转导相关,且其表达量在几种癌症中会经常发生变化。Cyr61在器官局限性前列腺癌中呈高度表达。此外,Cyr61的表达水平与较低的疾病复发风险相关,且在血清中能够定量测定。综合考虑,上述结果表明Cyr61是一种潜在的,临床上实用的、基于组织和血清的生物标记物,可用于区分致死及非致死性前列腺癌。

关键词:Cyr61,致死性前列腺癌,非致死性前列腺癌,过度诊断,过度治疗,前列腺癌

此摘要文献来源:
Naoki Terada, Prakash Kulkarni and Robert H Getzenberg. Cyr61 is a potential prognostic marker for prostate cancer. Asian J Androl 2012; 14: 405–408.

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.